Consistent with these observations, our study indicates that irisin treatment significantly improved systemic insulin resistance and mitigated the extent of hyperglycemia and hyperinsulinemia, which is associated with cardiac dysfunction. The gene discussed is FNDC5; the disease is Hyperinsulinemia.